Financial Performance - Total revenue reached $3.8 billion, representing a 16% year-over-year increase[4][10] - Fee revenue grew 15% year-over-year to $3.0 billion, while net interest income rose 17% to $835 million[4][10] - Diluted earnings per share (EPS) increased 39% year-over-year to $2.84 on an ex-notables basis[4][6] - Pre-tax margin stood at 29.0% with a return on average tangible common equity (ROTCE) of 20.1%[4][6] Business Momentum and Operations - Investment Services achieved a record assets under custody and/or administration (AUC/A) of $54.5 trillion[4][16] - Investment Management reported $5.6 trillion in assets under management (AUM) with $49 billion in total net inflows[4][19] - Foreign exchange trading services revenue rose 29% year-over-year to $435 million, driven by record trading volumes[4][27][29] - Software services revenue increased 7% year-over-year to $169 million, supported by a 24% growth in professional services[4][34][36] Capital and Liquidity - Total capital return to shareholders reached $633 million, resulting in a 90% payout ratio[4][54] - Standardized Common Equity Tier 1 (CET1) ratio was reported at 10.6% at quarter-end[4][47][54]

Financial Performance - Net income available to common shareholders reached $539 million for the first quarter of 2026[4] - Total revenue was reported at $1,873 million, with a diluted earnings per share of $0.62[4] - Return on average tangible common equity stood at 18.26%[4] - Net interest income (NII) decreased 2.6% quarter-over-quarter to $1,248 million, with a net interest margin (NIM) of 3.67%[14][21] Loan and Deposit Trends - Average loan balances grew 1% quarter-over-quarter, with expectations for full-year 2026 average loan growth in the low single digits[8] - Average deposit balances increased modestly, with total deposit costs declining to 1.20%[10][12] - Full-year 2026 NII is projected to grow between 2.5% and 4% compared to 2025[23][54] Asset Quality and Capital - Net charge-offs decreased by 5 basis points to 0.54% of average loans[4][43] - The allowance for credit losses (ACL) ratio declined to 1.68%[42][43] - The Common Equity Tier 1 (CET1) ratio, inclusive of AOCI, is estimated at 9.4%[50][53]

Financial Performance - GAAP net income attributable to common shareholders reached $291 million in 1Q 2026, while Adjusted EPS stood at $1.11[10] - Adjusted total net revenue for the quarter was $2.179 billion, reflecting a steady performance compared to previous periods[10] - Core ROTCE reached 11.1% in 1Q 2026, maintaining consistency with the prior quarter[10] - Adjusted efficiency ratio remained stable at 50.8%[10] Business Segment Highlights - Auto Finance segment generated $336 million in pre-tax income, with consumer originations totaling $11.5 billion, a 13% increase year-over-year[41][46] - Insurance segment reported $28 million in pre-tax income and $87 million in core pre-tax income, with written premiums of $389 million[50][54] - Corporate Finance segment achieved $94 million in pre-tax income, supported by $13.7 billion in held-for-investment balances[57][64] Capital and Asset Quality - CET1 ratio was 10.1% in 1Q 2026, providing $4.7 billion of capital above the Federal Reserve Board requirement of 7.1%[26] - Consolidated net charge-off rate was 1.21% in 1Q 2026, showing a 15bps improvement year-over-year[28] - Retail deposit balances remained strong at $146 billion, supported by 68 consecutive quarters of customer growth[16]

Financial Performance - Autoliv achieved record first-quarter sales of $2.753 billion, representing a year-over-year increase from $2.578 billion[11, 12, 44] - Adjusted operating income reached $245 million, compared to $255 million in the same period last year, with an adjusted operating margin of 8.9%[12, 44] - The company paid a dividend of $0.87 per share, totaling a $65 million payout to shareholders[10, 44] - Adjusted earnings per share (EPS) on a diluted basis was $2.05, compared to $2.15 in the first quarter of 2025[44, 92] Market Growth and Regional Dynamics - Sales to Chinese OEMs increased by nearly 30%, driven by recent product launches[10] - India emerged as a key contributor to growth, supported by a strong local manufacturing footprint[10, 30] - Global light vehicle production (LVP) experienced a decline of 3.4% during the quarter[20, 44] - The company outperformed global LVP by 4 percentage points in terms of organic sales growth[27] Operational and Strategic Outlook - The full-year 2026 guidance maintains an adjusted operating margin target of approximately 10.5% to 11% and operating cash flow of around $1.2 billion[78] - Autoliv expanded its safety portfolio by launching the first commercially ready airbag specifically developed for commuter scooters[9, 10] - The net debt to EBITDA leverage ratio remained at 1.3x, staying below the long-term target limit of 1.5x[66, 89]

Financial Performance (Q1 2026) - ASML reported total net sales of €8.8 billion and net income of €2.8 billion for the first quarter of 2026[1] - The company achieved a gross margin of 53.0% and an operating margin of 36.0% during the quarter[8] - Net system sales reached €6.3 billion, while Installed Base Management sales contributed €2.5 billion[8] - Basic earnings per share for Q1 2026 were reported at €7.15[8] - ASML repurchased approximately 0.9 million shares for a total value of around €1.1 billion in Q1 2026[26] Market Outlook and Strategic Goals - ASML projects total net sales for 2026 to be between €36 billion and €40 billion, with a gross margin ranging from 51% to 53%[1][30] - For Q2 2026, the company expects total net sales between €8.4 billion and €9.0 billion with a gross margin of 51% to 52%[28] - The semiconductor industry is expected to see long-term growth driven by AI, with a 2030 annual revenue target between approximately €44 billion and €60 billion and a gross margin of 56% to 60%[6] - The company anticipates that advanced logic and memory processes will require an increased number of critical lithography exposures to support innovation[6]

Financial Performance - Citigroup achieved its best quarterly revenue in a decade, reaching $24.6 billion, a 14% increase year-over-year[5][7] - Net income rose to $5.8 billion, representing a 42% growth compared to the first quarter of 2025[5][14] - Diluted EPS reached $3.06, marking a 56% increase year-over-year[5][7] - Return on Tangible Common Equity (RoTCE) improved to 13.1%, up approximately 400 basis points year-over-year[7][14] Operational Efficiency and Capital - Operating expenses were $14.3 billion, with an efficiency ratio of approximately 58%, an improvement of about 410 basis points year-over-year[7][14] - The CET1 Capital Ratio stood at 12.7%, which is approximately 110 basis points above current regulatory requirements[7][23] - Citigroup returned approximately $7.4 billion to common shareholders through share repurchases and dividends, including $6.3 billion in share repurchases[7][55] Business Segment Highlights - Services revenue reached $6.1 billion, up 17% year-over-year, marking the highest first-quarter revenue in a decade[9][10][28] - Markets revenue grew 19% year-over-year to $7.2 billion, driven by strong performance in both Fixed Income and Equity Markets[33][36] - Wealth segment revenue increased 11% year-over-year to $3.1 billion, with an EBT margin of 18%[41][43]

Financial Performance and Overview - Earnings per diluted share reached $1.60, representing a 15% increase compared to the prior year period[3] - Net income for the first quarter of 2026 was reported at $5.3 billion, which includes $135 million of discrete tax benefits related to the resolution of prior period matters[8] - Total revenue grew by 6% to reach $21.4 billion, supported by a 5% increase in net interest income up to $12.1 billion and an 8% increase in noninterest income up to $9.4 billion[8] Balance Sheet and Credit Quality - Average loans experienced a 10% year-over-year increase, reaching $996.0 billion, while average deposits grew by 6% to total $1.4 trillion[8] - Provision for credit losses stood at $1.1 billion, with total net loan charge-offs also recorded at $1.1 billion, representing 0.45% of annualized average loans[8] Capital and Liquidity - Common Equity Tier 1 capital was recorded at $135.4 billion, yielding a CET1 ratio of 10.3% under the Standardized Approach[8] - The company successfully returned $5.4 billion to shareholders, which included $4.0 billion executed through common share repurchases[7]

Financial Performance - 1Q26 net income reached $16.5 billion, representing a 13% increase year-over-year[2],[7] - Managed revenue grew to $50.5 billion, up 10% year-over-year, supported by a 9% rise in net interest income to $25.5 billion and an 11% rise in noninterest revenue to $25.1 billion[7] - ROTCE stood at 23%, while the managed overhead ratio was reported at 53%[2],[4] - Total expenses were $26.9 billion, an increase of 14% year-over-year, primarily driven by higher compensation and revenue-related costs[7] Balance Sheet and Capital - Average loans increased 11% year-over-year to $1.5 trillion, and average deposits rose 7% year-over-year to $2.6 trillion[2] - The standardized CET1 capital ratio was 14.3%, with CET1 capital totaling $291 billion[2],[8] - Capital distribution included $4.1 billion in common dividends and $8.1 billion in common stock net repurchases[2] Business Segment Highlights - Consumer & Community Banking (CCB) generated $5.0 billion in net income, up 12% year-over-year[22] - Commercial & Investment Bank (CIB) reported $9.0 billion in net income, a 30% increase year-over-year, with Markets revenue rising 20% to $11.6 billion[28] - Asset & Wealth Management (AWM) achieved $1.8 billion in net income, up 12% year-over-year, with AUM reaching $4.8 trillion[31]

Financial Performance - Worldwide sales reached $24.1 billion in Q1 2026, representing a 9.9% reported growth and 6.4% operational growth[36][37] - Innovative Medicine segment achieved 7.4% operational sales growth, driven by strong performance in Oncology and Neuroscience[20][39] - MedTech segment delivered 4.6% operational sales growth, supported by commercial execution and innovation across its platforms[31][43] - Adjusted net earnings were $6.6 billion, with adjusted diluted EPS of $2.70 for the first quarter of 2026[38][45] Strategic Outlook and Guidance - The company increased its 2026 operational sales guidance midpoint to 6.4%, with a projected range of $99.7 billion to $100.7 billion[51] - Adjusted operational EPS guidance midpoint for 2026 was raised to 5.7%, reflecting a range of $11.30 to $11.50[51] - Capital allocation priorities remain focused on organic business needs, competitive dividends, share repurchases, and strategic M&A, with $3.5 billion invested in R&D during Q1 2026[49] Operational Highlights - The launch of ICOTYDE for plaque psoriasis treatment represents a key milestone in the Immunology portfolio, offering a new systemic treatment option[23][27] - STELARA performance impacted operational results by approximately (920) basis points due to biosimilar competition and market dynamics[22][39] - MedTech growth was bolstered by double-digit performance in the Abiomed and Shockwave portfolios, alongside strong adoption of new product launches[43]

Financial Performance and Profitability - Consolidated revenue for FY2026 was $150.5 million, compared to $151.3 million in FY2025[14][42] - Q4 FY2026 gross profit margin contracted by 256 basis points year-over-year to 30.2% due to lower volume and product mix[16][42] - Adjusted operating margin expanded by 220 basis points from the first half to the second half of FY2026, supported by higher volume and lower costs[20] - Adjusted EBITDA for FY2026 reached $12.7 million, representing an 8.4% margin, compared to $12.3 million and 8.2% in FY2025[44] Segment Operations and Strategic Initiatives - Product ID segment sales in 2H FY2026 increased by 4.2% compared to 1H FY2026, with Q4 orders growing by $2.9 million year-over-year[9][15][30] - Aerospace segment delivered strong performance with ToughWriter printers now representing over 80% of flight deck printer shipments[15] - Aerospace orders reached $13.6 million in Q4 FY2026 with a book-to-bill ratio of 122%[30] - A major Aerospace royalty obligation is set to lapse in Q3 FY2027, which will provide a $2 million annualized contribution to gross profit[16][38] Capital Structure and Outlook - The company reduced total debt by $9.1 million during FY2026, ending the year with $37.6 million in debt and $4.1 million in cash[27][29] - For FY2027, the company expects mid-single digit revenue growth and further expansion of the adjusted EBITDA margin[36]